piperazine has been researched along with amg 511 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, KL; Cee, VJ; Hong, FT; Hughes, PE; Jiang, J; Lanman, BA; McCarter, JD; Mullady, EL; Norman, MH; Pettus, LH; Reed, AB; San Miguel, T; Subramanian, R; Tasker, AS; Wang, L; Whittington, DA; Wu, T; Wurz, RP; Zalameda, L; Zhang, N | 1 |
1 other study(ies) available for piperazine and amg 511
| Article | Year |
|---|---|
Phosphoinositide-3-kinase inhibitors: evaluation of substituted alcohols as replacements for the piperazine sulfonamide portion of AMG 511.
Topics: Alcohols; Animals; Female; Half-Life; Liver; Male; Mice; Mice, Nude; Molecular Conformation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazine; Piperazines; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Sprague-Dawley; Signal Transduction; Structure-Activity Relationship; Sulfonamides; TOR Serine-Threonine Kinases; Triazines | 2014 |